Viruses that stay: herpesviruses

Latency, reactivation, and an immune system on permanent guard duty.

7. Real enemies About 5 min read

Herpesviruses are unusual because you never get rid of them. After the first infection they go quiet inside your cells for the rest of your life, and your immune system spends that whole time keeping them there. Most adults carry several.

The family

Virus Lies dormant in First infection When it comes back
HSV-1 Nerve ganglia, usually near the face Often no symptoms; cold sores or genital herpes Cold sores, genital outbreaks
HSV-2 Nerve ganglia at the base of the spine Often no symptoms; genital herpes Genital outbreaks, or silent shedding
Varicella-zoster (VZV) Nerve ganglia Chickenpox Shingles
Epstein-Barr (EBV) Memory B cells Glandular fever, or nothing if in childhood Usually silent; some cancers
Cytomegalovirus (CMV) Myeloid cells Usually no symptoms Dangerous in pregnancy or when immune-suppressed
HHV-6, HHV-7 T cells and others Roseola in babies Mostly a problem after transplants
HHV-8 B cells, blood vessel lining Usually no symptoms Kaposi's sarcoma, when immune-suppressed

How common they are: EBV reaches around 90 to 95% of adults, and VZV over 90% of those who haven't been vaccinated. WHO estimates about 64% of people under 50 worldwide have HSV-1 and about 13% of people aged 15 to 49 have HSV-2. Many don't know.

How latency works

During latency, the virus shuts down almost all of its genes, so there's little for the immune system to see. In neurons, the viral DNA sits in the cell's nucleus as a loop, and because neurons don't divide, it needn't copy itself. EBV takes the other route: it hides in long-lived memory B cells and is copied whenever they divide.

Latency isn't entirely silent. Viral genes switch on from time to time, and the virus tries to come back out. A lot of immune resources go on stopping it. In genital skin, HSV-2-specific killer T cells have been seen staying close to nerve endings for months after healing, and a surprisingly high share of memory T cells in older people are devoted to CMV.

An illustration, not data. Each spike is the virus coming out of hiding, and most never cause a sore. The picture shows the moment marked on the trace, which you can drag: a virus asleep in a nerve cell, and the T cells that guard it. It's a cartoon, not to scale: the spikes are drawn far wider than life so they can be seen (many silent ones are over within hours), and most silent ones still put a little virus on the skin, which is how it usually spreads.

Reactivation is mostly silent

An outbreak is what happens when control slips for long enough. Most reactivation produces no symptoms at all. In one study of 498 people who took daily genital swabs, HSV-2 was detected on 20% of days in those with symptomatic infection and 10% of days even in those who'd never had symptoms. This is how herpes usually spreads, from people with no sign of an outbreak.

Reactivation has been linked with:

Outbreaks usually become less frequent over the years, particularly after the first year.

EBV: a special case

EBV infects B cells and pushes them to multiply, which no other common human virus does in quite the same way. Most of what you feel in glandular fever is the response: enormous expansion of killer T cells, seen as "atypical lymphocytes" on the blood film, in the swollen tonsils and nodes. People's fatigue often lingers after this, usually for weeks and occasionally much longer.

EBV is also linked to serious later problems. In a study of 10 million young US service members, MS risk rose 32-fold after EBV infection but not after other viruses, and only one of 801 cases tested was EBV-negative at the point of the last blood sample. EBV is now seen as a likely necessary cause of MS, although almost everyone infected never gets it. The virus is also tied to some lymphomas and nasopharyngeal cancer.

Antivirals. For HSV and shingles, aciclovir and valaciclovir shorten outbreaks, best started at the first sign (within 72 hours for shingles). Taken daily for HSV, they cut outbreaks and shedding, though short silent shedding continues. In one trial, daily valaciclovir about halved transmission to a partner. They don't remove the virus, and they aren't a proven treatment for glandular fever. Vaccines: chickenpox and shingles vaccines work well. There's no licensed vaccine for HSV, EBV or CMV yet, despite decades of attempts. Interpreting a blood test for these viruses is tricky, as Antibody tests explains.

Does low-level reactivation make you feel unwell? Raised antibodies to EBV and other herpesviruses are reported in long COVID and some people with ME/CFS, suggesting that the viruses are being less well controlled. But that could be a cause, an effect or just a marker of a stressed immune system. No study has yet shown that it causes the symptoms, and antivirals haven't been shown to work for this.

Herpesviruses don't get cleared. They're held down by T cells for life, and an outbreak means control has briefly slipped. Most reactivation you never notice.

Sources and further reading

An unhandled error has occurred. Reload ๐Ÿ—™